LC BEAD
Device
Biocompatibles UK Ltd
Total Payments
$1.3M
Transactions
219
Doctors
53
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $465.15 | 20 | 15 |
| 2020 | $554,379 | 12 | 9 |
| 2019 | $28,645 | 14 | 8 |
| 2018 | $193,823 | 42 | 4 |
| 2017 | $489,512 | 131 | 22 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $847,981 | 34 | 66.9% |
| Consulting Fee | $269,323 | 39 | 21.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,588 | 27 | 6.2% |
| Travel and Lodging | $45,660 | 73 | 3.6% |
| Space rental or facility fees (teaching hospital only) | $22,625 | 7 | 1.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,675 | 2 | 0.1% |
| Food and Beverage | $858.71 | 35 | 0.1% |
| Education | $114.05 | 2 | 0.0% |
Payments by Type
Research
$847,981
34 transactions
General
$418,843
185 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BARIATRIC EMBOLIZATION OF ARTERIES WITH IMAGING VISIBLE EMBOLICS | Boston Scientific Corporation | $530,307 | 0 |
| LEGACY Study | Biocompatibles UK Ltd | $64,667 | 0 |
| TARGET Study | Biocompatibles UK Ltd | $50,743 | 0 |
| Doxorubicin-Eluting LC Bead M1 for Patients with HCC | Biocompatibles UK Ltd | $50,000 | 0 |
| Irinotecan-Eluting LC Bead-M1 DEBIRI-M1 for Patients with Liver Metastases | Biocompatibles UK Ltd | $50,000 | 0 |
| Intravital Imaging of Embolization using Drug-Eluting Beads & Glass Microspheres in Animal Model of HCC | Biocompatibles UK Ltd | $24,286 | 0 |
| Safety & Efficacy of LC Bead Lumi for Prostatic Artery Embolization PAE | Biocompatibles UK Ltd | $22,241 | 0 |
| Retrospective Analysis of Safety & Efficacy DEBDOX M1 in HCC & DEBIRI M1 in mCRC | Biocompatibles UK Ltd | $18,702 | 0 |
| Safety & Efficacy of LC Bead Lumi for Prostatic Artery Embolization (PAE) | Boston Scientific Corporation | $14,202 | 0 |
| Intravital Imaging of Embolization using Drug-Eluting Beads & Glass Microspheres in Animal Model of HCC | BOSTON SCIENTIFIC CORPORATION | $8,095 | 0 |
| LUMI PPE - BTG-13002-01 | Biocompatibles UK Ltd | $7,500 | 0 |
| Prognosis of Liver Transplant Patients Undergoing Regional Therapy for HCC | Biocompatibles UK Ltd | $5,000 | 0 |
| LUMI PPE - BTG-13002-02 | Biocompatibles UK Ltd | $975.00 | 0 |
| LUMI PPE - BTG-13002-05 | Biocompatibles UK Ltd | $512.50 | 0 |
| LUMI PPE - BTG-13002-11 | Biocompatibles UK Ltd | $500.00 | 0 |
| LUMI PPE - BTG-13002-03 | Biocompatibles UK Ltd | $250.00 | 0 |
Top Doctors Receiving Payments for LC BEAD
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Durham, NC | $870,606 | 41 |
| , MD | Vascular & Interventional Radiology | Miami, FL | $129,174 | 21 |
| , MD | Vascular & Interventional Radiology | Milwaukee, WI | $46,350 | 11 |
| , DO | Diagnostic Radiology | Englewood, CO | $26,428 | 6 |
| , M.D | Diagnostic Radiology | Englewood, CO | $25,539 | 6 |
| , M.D., PHD | Diagnostic Radiology | Washington, DC | $15,900 | 2 |
| , MD | Specialist | New York, NY | $15,284 | 10 |
| , MD | Vascular & Interventional Radiology | Chicago, IL | $13,213 | 7 |
| , MD | Hematology & Oncology | Denver, CO | $12,430 | 7 |
| , M.D | Diagnostic Radiology | Houston, TX | $12,197 | 8 |
| , M.D - PHD | Radiation Oncology | Orlando, FL | $12,142 | 9 |
| , M.D | Vascular & Interventional Radiology | Seattle, WA | $11,848 | 10 |
| , MD | Diagnostic Radiology | Miami, FL | $9,600 | 2 |
| , M.D | Diagnostic Radiology | Baltimore, MD | $8,244 | 7 |
| , M.D | Vascular & Interventional Radiology | Chicago, IL | $6,954 | 6 |
| , M.D | Vascular & Interventional Radiology | Orange, CA | $6,837 | 3 |
| , DO | Cardiovascular Disease | Columbus, OH | $6,560 | 4 |
| , MD, MMS | Diagnostic Radiology | Houston, TX | $6,409 | 4 |
| , MD | Diagnostic Radiology | New York, NY | $6,111 | 5 |
| , MD | Vascular & Interventional Radiology | Chicago, IL | $4,653 | 3 |
| , M.D | Vascular & Interventional Radiology | Miami, FL | $4,205 | 1 |
| , M.D | Internal Medicine | Boston, MA | $4,061 | 2 |
| , M.D | Vascular & Interventional Radiology | Desoto, TX | $2,447 | 2 |
| , MD | Neurological Surgery | Chesterton, IN | $2,400 | 1 |
| , MD | Radiation Oncology | Miami, FL | $1,935 | 3 |
Ad
Manufacturing Companies
- Biocompatibles UK Ltd $567,989
- Boston Scientific Corporation $546,303
- Biocompatibles, Inc. $90,833
- BTG International, Inc. $53,158
- BOSTON SCIENTIFIC CORPORATION $8,541
Product Information
- Type Device
- Total Payments $1.3M
- Total Doctors 53
- Transactions 219
About LC BEAD
LC BEAD is a device associated with $1.3M in payments to 53 healthcare providers, recorded across 219 transactions in the CMS Open Payments database. The primary manufacturer is Biocompatibles UK Ltd.
Payment data is available from 2017 to 2021. In 2021, $465.15 was paid across 20 transactions to 15 doctors.
The most common payment nature for LC BEAD is "Unspecified" ($847,981, 66.9% of total).
LC BEAD is associated with 16 research studies, including "BARIATRIC EMBOLIZATION OF ARTERIES WITH IMAGING VISIBLE EMBOLICS" ($530,307).